文献速递骨显像与常规 SPECT肿瘤 PET/CT

前列腺癌骨转移:骨显像与PET显像的比较

Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging.
PubMed 文献 · Semin Nucl Med · 2023-08-17

本文综述前列腺癌骨转移的影像学检测方法,比较SPECT及SPECT/CT骨显像与不同放射性药物PET显像的优缺点,并介绍杂交扫描仪、人工智能及影像组学在分子影像识别前列腺癌骨转移方面的最新进展。

要点

  • 骨显像虽经济且广泛可用,但假阳性率高。
  • PET/CT与PET/MRI可克服标准影像方法的局限,为骨转移检测提供有前景的替代方案。
  • 人工智能与影像组学可减少观察者间差异、提高准确性并节省时间。

核心结论

  • PET/CT与PET/MRI能克服标准影像方法的局限,为前列腺癌骨转移检测提供有前景的替代方案。
  • 人工智能与影像组学技术在减少观察者间差异、提高准确性及节省时间方面已显示出显著进展。

研究设计与样本

  • 本文为综述,概述SPECT及SPECT/CT骨显像与不同放射性药物PET显像方法在前列腺癌骨转移检测中的优缺点。

主要发现

  • 骨显像虽然成本低且广泛可用,但假阳性率高。
  • 靶向细胞分裂活性或癌症特异性膜蛋白的多种放射性示踪剂以及骨靶向药物已被开发并测试。
  • 使用氟-18和镓-68等正电子发射同位素标记可降低辐射剂量且不影响生物学特性。
  • 将人工智能与影像组学技术整合到医学影像中,在减少观察者间差异、提高准确性及节省时间方面已显示出显著进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate cancer is the second most common cause of malignancy among men, with bone metastasis being a significant source of morbidity and mortality in advanced cases. Detecting and treating bone metastasis at an early stage is crucial to improve the quality of life and survival of prostate cancer patients. This objective strongly relies on imaging studies. While CT and MRI have their specific utilities, they also possess certain drawbacks. Bone scintigraphy, although cost-effective and widely available, presents high false-positive rates. The emergence of PET/CT and PET/MRI, with their ability to overcome the limitations of standard imaging methods, offers promising alternatives for the detection of bone metastasis. Various radiotracers targeting cell division activity or cancer-specific membrane proteins, as well as bone seeking agents, have been developed and tested. The use of positron-emitting isotopes such as fluorine-18 and gallium-68 for labeling allows for a reduced radiation dose and unaffected biological properties. Furthermore, the integration of artificial intelligence (AI) and radiomics techniques in medical imaging has shown significant advancements in reducing interobserver variability, improving accuracy, and saving time. This article provides an overview of the advantages and limitations of bone scan using SPECT and SPECT/CT and PET imaging methods with different radiopharmaceuticals and highlights recent developments in hybrid scanners, AI, and radiomics for the identification of prostate cancer bone metastasis using molecular imaging.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mohseninia N, Zamani-Siahkali N, Harsini S, et al. Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging. Semin Nucl Med. 2023. PMID: 37596138. doi:10.1053/j.semnuclmed.2023.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。